Skip to main content

Preliminary Report: Evaluation of storage conditions and cryococktails during peripheral blood mononuclear cell cryopreservation

Cosentino LM, Corwin W, Baust JM, Diaz-Mayoral N, Cooley H, Shao W, Van Buskirk R, Baust JG

Publication: Cell Preservation Technology (2007) • Vol 5 • Page 189

Purpose

The purpose of this paper was to determine the effects of freezing media and temperature cycling on peripheral blood mononuclear cell (PBMC) viability.

Conclusion

PBMC stored in CryoStar had increased viability at 1 h post-thaw when compared to PBMC stored in a RPMI based freezing media. However, by 24 h post-thaw no difference in viability was found between specimens stored in the two different freezing media. By 24 h, a significant decline in viability in cycled specimens was noted and was independent of the freezing media used. In the temperature cycled specimens, necrosis was elevated compared to fixed temperature PBMC. Apoptosis was also elevated in cycled specimens stored in either CryoStar or RPMI based media. The addition of caspase inhibitors to CryoStar freezing media did not increase cell viability at 24 h in static temperature specimens, but did increase viability of cycled specimens. In conclusion, temperature cycling as occurs during routine shipping and storage alters PBMC viability, but these effects may be partially attenuated by the addition of caspase inhibitors to the freezing media.

Studies (1)

Purpose

The purpose of this study was to determine the effects of freezing media and temperature cycling on PBMC viability using trypan blue and Vybrant apoptosis assay. PBMC were stored at a constant -150 degrees C or cycled 98 times between -150 and -80 degrees C before storage at -150 degrees C.

Summary of Findings

Cell viability was found to be significantly higher when quantified using trypan blue than when the Vybrant apoptosis assay was used. PBMC stored in CryoStar had increased viability at 1 h post-thaw when compared to PBMC stored in a RPMI based freezing media. However, by 24 h post-thaw, no difference in viability was found between specimens stored in the two different freezing media. Specimens that were cycled between -80 and -150 degrees C had a slight but non-significant increase in cell viability at 1 h compared to PBMC stored at static temperature, but by 24 h, a significant decline in viability in cycled specimens was noted and was independent of the freezing media used. In the temperature cycled specimens, necrosis was elevated compared to fixed temperature PBMC starting at 1 h, but was most notable at 4 h post-thaw. Apoptosis was also elevated in cycled specimens stored in either CryoStar or RPMI based media particularly at 4 and 8 h post-thaw. The addition of caspase inhibitors to CryoStar freezing media did not increase cell viability at 24 h in static temperature specimens, but did increase viability of cycled specimens. This was attributed to a significant decrease in necrosis at 4 h and apoptosis at 8 h in cycled specimens containing protease inhibitors. In conclusion, temperature cycling as occurs during routine shipping and storage alters PBMC viability, but these effects may be partially attenuated by the addition of caspase inhibitors to the freezing media.

  • Biospecimens

    CellBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    Cell count/volumeLight microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood and blood products
    Peripheral blood mononuclear cells
    Biospecimen PreservationFixative additive/buffer
    Cryostar
    Cryostar with caspase inhibitors
    Fetal bovine serum with DMSO
    StorageStorage duration
    30 days
    StorageStorage temperature
    -150 degrees C
    -80 to -150 degrees C (cycling)